Cortical hyperexcitability and plasticity in Alzheimer’s disease: developments in understanding and management

References

• Soria Lopez JA, González HM, Léger GC. Alzheimer’s disease. Handb Clin Neurol. 2019;167:231–255.
   PubMedGoogle Scholar
• Chang CH, Lane HY, Lin CH. Brain stimulation in alzheimer’s disease. Front Psychiatry. 2018;9(201).
   Google Scholar
• Hodges JR. Alzheimer’s disease and the frontotemporal dementias: contributions to clinico-pathological studies, diagnosis, and cognitive neuroscience. J Alzheimers Dis. 2013;33(Suppl 1):S211–217.
   PubMedGoogle Scholar
• Cantone M, Di Pino G, Capone F, et al. The contribution of transcranial magnetic stimulation in the diagnosis and in the management of dementia. Clin Neurophysiol. 2014;125(8):1509–1532
   PubMed Web of Science ®Google Scholar
• Birks JS, Harvey RJ. Donepezil for dementia due to Alzheimer’s disease. Cochrane Database Syst Rev. 2018;6(6):Cd001190.
   PubMedGoogle Scholar
• Eisen A, Kiernan M, Mitsumoto H, et al. Amyotrophic lateral sclerosis: a long preclinical period? J Neurol Neurosurg Psychiatry. 2014;85(11):1232–1238.
   PubMed Web of Science ®Google Scholar
• Jimenez-Balado J, Eich TS. GABAergic dysfunction, neural network hyperactivity and memory impairments in human aging and Alzheimer’s disease. Semin Cell Dev Biol. 2021;116:146–159.
   PubMed Web of Science ®Google Scholar
• de Boer EMJ, Orie VK, Williams T, et al. TDP-43 proteinopathies: a new wave of neurodegenerative diseases. J Neurol Neurosurg Psychiatry. 2020;92(92):86–95
   PubMedGoogle Scholar
• Coyle JT, Price DL, DeLong MR. Alzheimer’s disease: a disorder of cortical cholinergic innervation. Science. 1983;219(4589):1184–1190.
   PubMed Web of Science ®Google Scholar
• Cowburn R, Hardy J, Roberts P, et al. Regional distribution of pre- and postsynaptic glutamatergic function in Alzheimer’s disease. Brain Res. 1988;452(1–2):403–407.
   PubMed Web of Science ®Google Scholar
• Pike CJ, Cotman CW. Cultured GABA-immunoreactive neurons are resistant to toxicity induced by beta-amyloid. Neuroscience. 1993;56(2):269–274.
   PubMed Web of Science ®Google Scholar
• Busche MA, Eichhoff G, Adelsberger H, et al. Clusters of hyperactive neurons near amyloid plaques in a mouse model of Alzheimer’s disease. Science. 2008;321(5896):1686–1689
   PubMed Web of Science ®Google Scholar
• Cirrito JR, Yamada KA, Finn MB, et al. Synaptic activity regulates interstitial fluid amyloid-beta levels in vivo. Neuron. 2005;48(6):913–922
   PubMed Web of Science ®Google Scholar
• Wu JW, Hussaini SA, Bastille IM, et al. Neuronal activity enhances tau propagation and tau pathology in vivo. Nat Neurosci. 2016;19(8):1085–1092
   PubMed Web of Science ®Google Scholar
• Ulrich D. Amyloid-β Impairs Synaptic Inhibition via GABA(A) receptor endocytosis. J Neurosci. 2015;35(24):9205–9210.
   PubMed Web of Science ®Google Scholar
• Frisoni GB, Fox NC, Jack CR Jr., et al. The clinical use of structural MRI in Alzheimer disease. Nat Rev Neurol. 2010;6(2):67–77.
   PubMed Web of Science ®Google Scholar
• Di Lazzaro V, Bella R, Benussi A, et al. Diagnostic contribution and therapeutic perspectives of transcranial magnetic stimulation in dementia. Clin Neurophysiol. 2021;132(10):2568–2607
   PubMed Web of Science ®Google Scholar
• DeTure MA, Dickson DW. The neuropathological diagnosis of Alzheimer’s disease. Mol Neurodegener. 2019;14(1):32.
   PubMed Web of Science ®Google Scholar
• Vidoni ED, Thomas GP, Honea RA, et al. Evidence of altered corticomotor system connectivity in early-stage Alzheimer’s disease. J Neurol Phys Ther. 2012;36(1):8–16.
   PubMed Web of Science ®Google Scholar
• Mecca AP, Chen MK, O’Dell RS, et al. In vivo measurement of widespread synaptic loss in Alzheimer’s disease with SV2A PET. Alzheimers Dement. 2020;16(7):974–982
   PubMed Web of Science ®Google Scholar
• Albert MS, DeKosky ST, Dickson D, et al. The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimer’s Dementia. 2011;7(3):270–279
   PubMed Web of Science ®Google Scholar
• Petersen RC, Caracciolo B, Brayne C, et al. Mild cognitive impairment: a concept in evolution. J Intern Med. 2014;275(3):214–228.
   PubMed Web of Science ®Google Scholar
• Rossini PM, Miraglia F, Vecchio F. Early dementia diagnosis, MCI-to-dementia risk prediction, and the role of machine learning methods for feature extraction from integrated biomarkers, in particular for EEG signal analysis. Alzheimer’s Dementia. 2022;18:2699–2706.
   PubMed Web of Science ®Google Scholar
• Petersen RC, Negash S. Mild cognitive impairment: an overview. CNS Spectr. 2008;13(1):45–53.
   PubMed Web of Science ®Google Scholar
• Jack CR Jr., Bennett DA, Blennow K, et al. NIA-AA Research Framework: toward a biological definition of Alzheimer’s disease. Alzheimers Dement. 2018;14(4):535–562
   PubMed Web of Science ®Google Scholar
• Dubois B, Feldman HH, Jacova C, et al. Advancing research diagnostic criteria for Alzheimer’s disease: the IWG-2 criteria. Lancet Neurol. 2014;13(6):614–629
   PubMed Web of Science ®Google Scholar
• Dubois B, Villain N, Frisoni GB, et al. Clinical diagnosis of Alzheimer’s disease: recommendations of the international working group. Lancet Neurol. 2021;20(6):484–496
   PubMed Web of Science ®Google Scholar
• Ritchie C, Smailagic N, Noel-Storr AH, et al. Plasma and cerebrospinal fluid amyloid beta for the diagnosis of Alzheimer’s disease dementia and other dementias in people with mild cognitive impairment (MCI). Cochrane Database Syst Rev. 2014;(2014(6):Cd008782.
   PubMedGoogle Scholar
• Benussi A, Grassi M, Palluzzi F, et al. Classification accuracy of TMS for the diagnosis of mild cognitive impairment. Brain Stimul. 2021;14(2):241–249
   PubMed Web of Science ®Google Scholar
• Benussi A, Grassi M, Palluzzi F, et al. Classification accuracy of transcranial magnetic stimulation for the diagnosis of neurodegenerative dementias. Ann Neurol. 2020;87(3):394–404
   PubMed Web of Science ®Google Scholar
• Benussi A, Alberici A, Ferrari C, et al. The impact of transcranial magnetic stimulation on diagnostic confidence in patients with Alzheimer disease. Alzheimers Res Ther. 2018;10(1):94
   PubMedGoogle Scholar
• Benussi A, Di Lorenzo F, Dell’Era V, et al. Transcranial magnetic stimulation distinguishes Alzheimer disease from frontotemporal dementia. Neurology. 2017;89(7):665–672
   PubMed Web of Science ®Google Scholar
• Barker AT, Jalinous R, Freeston IL. Non-invasive magnetic stimulation of human motor cortex. Lancet. 1985;1(8437):1106–1107.
   PubMed Web of Science ®Google Scholar
• Rossini PM, Burke D, Chen R, et al. Non-invasive electrical and magnetic stimulation of the brain, spinal cord, roots and peripheral nerves: basic principles and procedures for routine clinical and research application. An updated report from an I.F.C.N. Committee. Clin Neurophysiol. 2015;126(126):1071–1107
   PubMedGoogle Scholar
• Siebner HR, Funke K, Aberra AS, et al. Transcranial magnetic stimulation of the brain: what is stimulated? - A consensus and critical position paper. Clin Neurophysiol. 2022;140(59–97):59–97
   PubMedGoogle Scholar
• Reis J, Swayne OB, Vandermeeren Y, et al. Contribution of transcranial magnetic stimulation to the understanding of cortical mechanisms involved in motor control. J Physiol. 2008;586(2):325–351
   PubMed Web of Science ®Google Scholar
• Ilmoniemi RJ, Kičić D. Methodology for combined TMS and EEG. Brain Topogr. 2010;22(4):233–248.
   PubMed Web of Science ®Google Scholar
• Cros DC. K.H. motor evoked potentials. In: Chiappa KH, editor. Evoked potentials in clinical medicine. Philadelphia: Lippincott-Raven; 1997. p. 477–507.
   Google Scholar
• Cantone M, Lanza G, Vinciguerra L, et al. Age, height, and sex on motor evoked potentials: translational data from a large italian cohort in a clinical environment. Front Hum Neurosci. 2019;13:185.
   PubMed Web of Science ®Google Scholar
• Huang YZ, Rothwell JC. The effect of short-duration bursts of high-frequency, low-intensity transcranial magnetic stimulation on the human motor cortex. Clin Neurophysiol. 2004;115(5):1069–1075.
   PubMed Web of Science ®Google Scholar
• Rizzo V, Siebner H, Morgante F, et al. Paired associative stimulation of left and right human motor cortex shapes interhemispheric motor inhibition based on a Hebbian mechanism. Cereb Cortex. 2009;19(4):907–915.
   PubMed Web of Science ®Google Scholar
• Koch G, Ponzo V, Di Lorenzo F, et al. Hebbian and anti-Hebbian spike-timing-dependent plasticity of human cortico-cortical connections. J Neurosci. 2013;33(23):9725–9733.
   PubMed Web of Science ®Google Scholar
• Aberra AS, Wang B, Grill WM, et al. Simulation of transcranial magnetic stimulation in head model with morphologically-realistic cortical neurons. Brain Stimul. 2020;13(1):175–189.
   PubMed Web of Science ®Google Scholar
• Geeter ND, Dupré L, Crevecoeur G. Modeling transcranial magnetic stimulation from the induced electric fields to the membrane potentials along tractography-based white matter fiber tracts. J Neural Eng. 2016;13(2):026028.
   PubMed Web of Science ®Google Scholar
• Goodwin BD, Butson CR. Subject-specific multiscale modeling to investigate effects of transcranial magnetic stimulation. Neuromodulation: Technol Neural Interface. 2015;18(8):694–704.
   PubMed Web of Science ®Google Scholar
• Pashut T, Wolfus S, Friedman A, et al. Mechanisms of magnetic stimulation of central nervous system neurons. PLoS Comput Biol. 2011;7(3):e1002022
   PubMed Web of Science ®Google Scholar
• Day BL, Rothwell JC, Thompson PD, et al. Motor cortex stimulation in intact man. 2. Multiple descending volleys. Brain. 1987;110(Pt 5):1191–1209
   PubMedGoogle Scholar
• Di Lazzaro V, Rothwell JC. Corticospinal activity evoked and modulated by non-invasive stimulation of the intact human motor cortex. J Physiol. 2014;592(19):4115–4128.
   PubMed Web of Science ®Google Scholar
• Ilmoniemi RJ, Virtanen J, Ruohonen J, et al. Neuronal responses to magnetic stimulation reveal cortical reactivity and connectivity. Neuroreport. 1997;8(16):3537–3540
   PubMed Web of Science ®Google Scholar
• Rogasch NC, Sullivan C, Thomson RH, et al. Analysing concurrent transcranial magnetic stimulation and electroencephalographic data: a review and introduction to the open-source TESA software. Neuroimage. 2017;147(934–951):934–951
   PubMedGoogle Scholar
• Tremblay S, Rogasch NC, Premoli I, et al. Clinical utility and prospective of TMS-EEG. Clin Neurophysiol. 2019;130(5):802–844
   PubMed Web of Science ®Google Scholar
• Chen R, Tam A, Butefisch C, et al. Intracortical inhibition and facilitation in different representations of the human motor cortex. J Neurophysiol. 1998;80(6):2870–2881
   PubMed Web of Science ®Google Scholar
• Ziemann U, Chen R, Cohen LG, et al. Dextromethorphan decreases the excitability of the human motor cortex. Neurology. 1998;51(5):1320–1324.
   PubMed Web of Science ®Google Scholar
• Schilberg L, Ten Oever S, Schuhmann T, et al. Phase and power modulations on the amplitude of TMS-induced motor evoked potentials. PLoS One. 2021;16(9):e0255815.
   PubMed Web of Science ®Google Scholar
• Vucic S, Howells J, Trevillion L, et al. Assessment of cortical excitability using threshold tracking techniques. Muscle Nerve. 2006;33(4):477–486.
   PubMed Web of Science ®Google Scholar
• Fisher RJ, Nakamura Y, Bestmann S, et al. Two phases of intracortical inhibition revealed by transcranial magnetic threshold tracking. Exp Brain Res. 2002;143(240–248):240–248.
   PubMedGoogle Scholar
• Matamala JM, Howells J, Dharmadasa T, et al. Inter-session reliability of short-interval intracortical inhibition measured by threshold tracking TMS. Neurosci Lett. 2018;674:18–23.
   PubMed Web of Science ®Google Scholar
• Samusyte G, Bostock H, Rothwell J, et al. Short-interval intracortical inhibition: comparison between conventional and threshold-tracking techniques. Brain Stimul. 2018;11(806–817):806–817.
   PubMedGoogle Scholar
• Chen R, Cros D, Curra A, et al. The clinical diagnostic utility of transcranial magnetic stimulation: report of an IFCN committee. Clin Neurophysiol, (2008). 119(119),504–532
   Google Scholar
• Vucic S, van den Bos M, Menon P, et al. Utility of threshold tracking transcranial magnetic stimulation in ALS. Clin Neurophysiol Pract. 2018;3(164–172):164–172.
   PubMedGoogle Scholar
• Cantello R, Gianelli M, Civardi C, et al. Magnetic brain stimulation: the silent period after the motor evoked potential. Neurology. 1992;42(10):1951–1959.
   PubMed Web of Science ®Google Scholar
• Chen R, Lozano AM, Ashby P. Mechanism of the silent period following transcranial magnetic stimulation. Evidence from epidural recordings. Exp Brain Res. 1999;128(4):539–542.
   PubMed Web of Science ®Google Scholar
• Roick H, Von Giesen H, Benecke R. On the origin of the postexcitatory inhibition seen after transcranial magnetic brain stimulation in awake human subjects. Exp Brain Res. 1993;94(3):489–498.
   PubMed Web of Science ®Google Scholar
• Inghilleri M, Berardelli A, Cruccu G, et al. Silent period evoked by transcranial stimulation of the human cortex and cervicomedullary junction. J Physiol. 1993;466(521–534):521–534.
   PubMedGoogle Scholar
• Triggs WJ, Calvanio R, Macdonell RA, et al. Physiological motor asymmetry in human handedness: evidence from transcranial magnetic stimulation. Brain Res. 1994;636(270–276):270–276.
   PubMedGoogle Scholar
• Triggs WJ, Kiers L, Cros D, et al. Facilitation of magnetic motor evoked potentials during the cortical stimulation silent period. Neurology. 1993;43(12):2615–2620.
   PubMed Web of Science ®Google Scholar
• Kujirai T, Caramia MD, Rothwell JC, et al. Corticocortical inhibition in human motor cortex. J Physiol. 1993;471(501–519):501–519
   PubMedGoogle Scholar
• Ziemann U, Reis J, Schwenkreis P, et al. TMS and drugs revisited 2014. Clin Neurophysiol. 2015;126(10):1847–1868
   PubMed Web of Science ®Google Scholar
• Di Lazzaro V, Oliviero A, Meglio M, et al. Direct demonstration of the effect of lorazepam on the excitability of the human motor cortex. Clin Neurophysiol. 2000;111(5):794–799
   PubMed Web of Science ®Google Scholar
• Di Lazzaro V, Oliviero A, Pilato F, et al. Descending volleys evoked by transcranial magnetic stimulation of the brain in conscious humans: effects of coil shape. Clin Neurophysiol. 2002;113(1):114–119
   PubMed Web of Science ®Google Scholar
• Tokimura H, Ridding MC, Tokimura Y, et al. Short latency facilitation between pairs of threshold magnetic stimuli applied to human motor cortex. Electroencephalogr Clin Neurophysiol. 1996;101(4):263–272.
   PubMedGoogle Scholar
• Van den Bos MAJ, Menon P, Howells J, et al. Physiological processes underlying short interval intracortical facilitation in the human motor cortex. Front Neurosci. 2018;12(240).
   PubMedGoogle Scholar
• Ziemann U, Tergau F, Wischer S, et al. Pharmacological control of facilitatory I-wave interaction in the human motor cortex. A paired transcranial magnetic stimulation study. Electroencephalogr Clin Neurophysiol. 1998;109(4):321–330.
   PubMedGoogle Scholar
• Ziemann U. TMS and drugs. Clin Neurophysiol. 2004;115(1717–1729):1717–1729.
   PubMedGoogle Scholar
• Ilic TV, Meintzschel F, Cleff U, et al. Short-interval paired-pulse inhibition and facilitation of human motor cortex: the dimension of stimulus intensity. J Physiol. 2002;545(Pt 1):153–167.
   PubMed Web of Science ®Google Scholar
• Chen R, Cros D, Curra A, et al. The clinical diagnostic utility of transcranial magnetic stimulation: report of an IFCN committee. Clin Neurophysiol, (2008). 119(3),504–532.
   Google Scholar
• Cash RF, Noda Y, Zomorrodi R, et al. Characterization of glutamatergic and GABAA-mediated neurotransmission in motor and dorsolateral prefrontal cortex using paired-pulse TMS-EEG. Neuropsychopharmacology. 2017;42(2):502–511
   PubMed Web of Science ®Google Scholar
• Volz LJ, Hamada M, Rothwell JC, et al. What makes the muscle twitch: motor system connectivity and TMS-induced activity. Cereb Cortex. 2015;25(9):2346–2353.
   PubMed Web of Science ®Google Scholar
• Di Lazzaro V, Pilato F, Oliviero A, et al. Origin of facilitation of motor-evoked potentials after paired magnetic stimulation: direct recording of epidural activity in conscious humans. J Neurophysiol. 2006;96(4):1765–1771
   PubMed Web of Science ®Google Scholar
• Valls-Sole J, Pascual-Leone A, Wassermann EM, et al. Human motor evoked responses to paired transcranial magnetic stimuli. Electroencephalogr Clin Neurophysiol. 1992;85(6):355–364.
   PubMedGoogle Scholar
• McDonnell MN, Orekhov Y, Ziemann U. The role of GABA(B) receptors in intracortical inhibition in the human motor cortex. Exp Brain Res. 2006;173:86–93.
   PubMed Web of Science ®Google Scholar
• Sanger TD, Garg RR, Chen R. Interactions between two different inhibitory systems in the human motor cortex. J Physiol. 2001;530(Pt 2):307–317.
   PubMed Web of Science ®Google Scholar
• Tokimura H, Di Lazzaro V, Tokimura Y, et al. Short latency inhibition of human hand motor cortex by somatosensory input from the hand. J Physiol. 2000;523(Pt 2):503–513
   PubMed Web of Science ®Google Scholar
• Ziemann U. Pharmacology of TMS. Clin Neurophysiol. 2003;56:226–231.
   Google Scholar
• Di Lazzaro V, Oliviero A, Profice P, et al. Muscarinic receptor blockade has differential effects on the excitability of intracortical circuits in the human motor cortex. Exp Brain Res. 2000;135(4):455–461
   PubMed Web of Science ®Google Scholar
• Ferbert A, Priori A, Rothwell JC, et al. Interhemispheric inhibition of the human motor cortex. J Physiol. 1992;453(525–546):525–546.
   PubMedGoogle Scholar
• Hanajima R, Ugawa Y, Machii K, et al. Interhemispheric facilitation of the hand motor area in humans. J Physiol. 2001;531(Pt 3):849–859
   PubMed Web of Science ®Google Scholar
• Daskalakis ZJ, Christensen BK, Fitzgerald PB, et al. The mechanisms of interhemispheric inhibition in the human motor cortex. J Physiol. 2002;543(Pt 1):317–326.
   PubMed Web of Science ®Google Scholar
• Meyer BU, Roricht S, Grafin von Einsiedel H, et al. Inhibitory and excitatory interhemispheric transfers between motor cortical areas in normal humans and patients with abnormalities of the corpus callosum. Brain. 1995;118(Pt 2):429–440.
   PubMedGoogle Scholar
• Kukaswadia S, Wagle-Shukla A, Morgante F, et al. Interactions between long latency afferent inhibition and interhemispheric inhibitions in the human motor cortex. J Physiol. 2005;563(Pt 3):915–924.
   PubMed Web of Science ®Google Scholar
• Koch G, Fernandez Del Olmo M, Cheeran B, et al. Focal stimulation of the posterior parietal cortex increases the excitability of the ipsilateral motor cortex. J Neurosci. 2007;27(25):6815–6822
   PubMed Web of Science ®Google Scholar
• Strigaro G, Ruge D, Chen JC, et al. Interaction between visual and motor cortex: a transcranial magnetic stimulation study. J Physiol. 2015;593(10):2365–2377
   PubMed Web of Science ®Google Scholar
• Ugawa Y, Uesaka Y, Terao Y, et al. Magnetic stimulation over the cerebellum in humans. Ann Neurol. 1995;37(6):703–713.
   PubMed Web of Science ®Google Scholar
• Buch ER, Mars RB, Boorman ED, et al. A network centered on ventral premotor cortex exerts both facilitatory and inhibitory control over primary motor cortex during action reprogramming. J Neurosci. 2010;30(4):1395–1401.
   PubMed Web of Science ®Google Scholar
• Komssi S, Aronen HJ, Huttunen J, et al. Ipsi- and contralateral EEG reactions to transcranial magnetic stimulation. Clin Neurophysiol. 2002;113(2):175–184
   PubMed Web of Science ®Google Scholar
• Hallett M, Di Iorio R, Rossini PM, et al. Contribution of transcranial magnetic stimulation to assessment of brain connectivity and networks. Clin Neurophysiol. 2017;128(11):2125–2139
   PubMed Web of Science ®Google Scholar
• Ferreri F, Pasqualetti P, Maatta S, et al. Human brain connectivity during single and paired pulse transcranial magnetic stimulation. Neuroimage. 2011;54(1):90–102
   PubMed Web of Science ®Google Scholar
• Ferreri F, Ponzo D, Hukkanen T, et al. Human brain cortical correlates of short-latency afferent inhibition: a combined EEG-TMS study. J Neurophysiol. 2012;108(1):314–323
   PubMed Web of Science ®Google Scholar
• Ferreri F, Vecchio F, Ponzo D, et al. Time-varying coupling of EEG oscillations predicts excitability fluctuations in the primary motor cortex as reflected by motor evoked potentials amplitude: an EEG-TMS study. Hum Brain Mapp. 2014;35(5):1969–1980.
   PubMed Web of Science ®Google Scholar
• Premoli I, Castellanos N, Rivolta D, et al. TMS-EEG signatures of GABAergic neurotransmission in the human cortex. J Neurosci. 2014;34(16):5603–5612
   PubMed Web of Science ®Google Scholar
• Premoli I, Bergmann TO, Fecchio M, et al. The impact of GABAergic drugs on TMS-induced brain oscillations in human motor cortex. Neuroimage. 2017;163(1–12):1–12
   PubMedGoogle Scholar
• Belardinelli P, Konig F, Liang C, et al. TMS-EEG signatures of glutamatergic neurotransmission in human cortex. Sci Rep. 2021;11(1):8159
   PubMed Web of Science ®Google Scholar
• Bliss TV, Collingridge GL. A synaptic model of memory: long-term potentiation in the hippocampus. Nature. 1993;361(6407):31–39.
   PubMed Web of Science ®Google Scholar
• Larson J, Lynch G. Induction of synaptic potentiation in hippocampus by patterned stimulation involves two events. Science. 1986;232(4753):985–988.
   PubMed Web of Science ®Google Scholar
• Hess G, Aizenman CD, Donoghue JP. Conditions for the induction of long-term potentiation in layer II/III horizontal connections of the rat motor cortex. J Neurophysiol. 1996;75(5):1765–1778.
   PubMed Web of Science ®Google Scholar
• Stefan K, Kunesch E, Cohen LG, et al. Induction of plasticity in the human motor cortex by paired associative stimulation. Brain. 2000;123(Pt 3):572–584.
   PubMed Web of Science ®Google Scholar
• Stefan K, Kunesch E, Benecke R, et al. Mechanisms of enhancement of human motor cortex excitability induced by interventional paired associative stimulation. J Physiol. 2002;543(Pt 2):699–708.
   PubMed Web of Science ®Google Scholar
• Lee NJ, Ahn HJ, Jung KI, et al. Reduction of continuous theta burst stimulation-induced motor plasticity in healthy elderly with COMT Val158Met polymorphism. Ann Rehabil Med. 2014;38(5):658–664
   PubMedGoogle Scholar
• Hamada M, Murase N, Hasan A, et al. The role of interneuron networks in driving human motor cortical plasticity. Cereb Cortex. 2013;23(7):1593–1605.
   PubMed Web of Science ®Google Scholar
• Fried PJ, Pascual-Leone A, Bolo NR. Diabetes and the link between neuroplasticity and glutamate in the aging human motor cortex. Clin Neurophysiol. 2019;130(9):1502–1510.
   PubMed Web of Science ®Google Scholar
• Di Lorenzo F, Motta C, Bonnì S, et al. LTP-like cortical plasticity is associated with verbal memory impairment in Alzheimer’s disease patients. Brain Stimul. 2019;12(1):148–151
   PubMed Web of Science ®Google Scholar
• Huang YZ, Lu MK, Antal A, et al. Plasticity induced by non-invasive transcranial brain stimulation: a position paper. Clin Neurophysiol. 2017;128(11):2318–2329
   PubMed Web of Science ®Google Scholar
• Alagona G, Bella R, Ferri R, et al. Transcranial magnetic stimulation in Alzheimer disease: motor cortex excitability and cognitive severity. Neurosci Lett. 2001;314(1–2):57–60
   PubMed Web of Science ®Google Scholar
• Alagona G, Ferri R, Pennisi G, et al. Motor cortex excitability in Alzheimer’s disease and in subcortical ischemic vascular dementia. Neurosci Lett. 2004;362(2):95–98
   PubMed Web of Science ®Google Scholar
• Brem AK, Atkinson NJ, Seligson EE, et al. Differential pharmacological effects on brain reactivity and plasticity in Alzheimer’s disease. Front Psychiatry. 2013;4(124).
   PubMedGoogle Scholar
• de Carvalho M, de Mendonça A, Miranda PC, et al. Magnetic stimulation in Alzheimer’s disease. J Neurol. 1997;244(5):304–307.
   PubMed Web of Science ®Google Scholar
• Ferreri F, Pasqualetti P, Määttä S, et al. Motor cortex excitability in Alzheimer’s disease: a transcranial magnetic stimulation follow-up study. Neurosci Lett. 2011;492(2):94–98
   PubMed Web of Science ®Google Scholar
• Ferreri F, Pauri F, Pasqualetti P, et al. Motor cortex excitability in Alzheimer’s disease: a transcranial magnetic stimulation study. Ann Neurol. 2003;53(1):102–108.
   PubMed Web of Science ®Google Scholar
• Inghilleri M, Conte A, Frasca V, et al. Altered response to rTMS in patients with Alzheimer’s disease. Clin Neurophysiol. 2006;117(1):103–109
   PubMed Web of Science ®Google Scholar
• Hoeppner J, Wegrzyn M, Thome J, et al. Intra- and inter-cortical motor excitability in Alzheimer’s disease. J Neural Transm (Vienna). 2012;119(5):605–612
   PubMed Web of Science ®Google Scholar
• Issac TG, Chandra SR, Nagaraju BC. Transcranial magnetic stimulation in patients with early cortical dementia: a pilot study. Ann Indian Acad Neurol. 2013;16(4):619–622.
   PubMed Web of Science ®Google Scholar
• Khedr EM, Ahmed MA, Darwish ES, et al. The relationship between motor cortex excitability and severity of Alzheimer’s disease: a transcranial magnetic stimulation study. Neurophysiol Clin. 2011;41(3):107–113.
   PubMed Web of Science ®Google Scholar
• Di Lazzaro V, Oliviero A, Pilato F, et al. Motor cortex hyperexcitability to transcranial magnetic stimulation in Alzheimer’s disease. J Neurol Neurosurg Psychiatry. 2004;75(4):555–559
   PubMed Web of Science ®Google Scholar
• Di Lazzaro V, Oliviero A, Tonali PA, et al. Noninvasive in vivo assessment of cholinergic cortical circuits in AD using transcranial magnetic stimulation. Neurology. 2002;59(3):392–397.
   PubMed Web of Science ®Google Scholar
• Di Lazzaro V, Pilato F, Dileone M, et al. In vivo functional evaluation of central cholinergic circuits in vascular dementia. Clin Neurophysiol. 2008;119(11):2494–2500
   PubMed Web of Science ®Google Scholar
• Di Lazzaro V, Pilato F, Dileone M, et al. In vivo cholinergic circuit evaluation in frontotemporal and Alzheimer dementias. Neurology. 2006;66(7):1111–1113
   PubMed Web of Science ®Google Scholar
• Di Lazzaro V, Pilato F, Dileone M, et al. Functional evaluation of cerebral cortex in dementia with Lewy bodies. NeuroImage. 2007;37(2):422–429
   PubMed Web of Science ®Google Scholar
• Di Lorenzo F, Martorana A, Ponzo V, et al. Cerebellar theta burst stimulation modulates short latency afferent inhibition in Alzheimer’s disease patients. Front Aging Neurosci. 2013;5(2):1–8.
   PubMedGoogle Scholar
• Martorana A, Mori F, Esposito Z, et al. Dopamine modulates cholinergic cortical excitability in Alzheimer’s disease patients. Neuropsychopharmacology. 2009;34(10):2323–2328
   PubMed Web of Science ®Google Scholar
• Martorana A, Stefani A, Palmieri MG, et al. L-dopa modulates motor cortex excitability in Alzheimer’s disease patients. J Neural Transm (Vienna). 2008;115(9):1313–1319
   PubMed Web of Science ®Google Scholar
• Terranova C, SantAngelo A, Morgante F, et al. Impairment of sensory-motor plasticity in mild Alzheimer’s disease. Brain Stimul. 2013;6(1):62–66
   PubMed Web of Science ®Google Scholar
• Motta C, Di Lorenzo F, Ponzo V, et al. Transcranial magnetic stimulation predicts cognitive decline in patients with Alzheimer’s disease. J Neurol Neurosurg Psychiatry. 2018;89(12):1237–1242
   PubMed Web of Science ®Google Scholar
• Pennisi G, Alagona G, Ferri R, et al. Motor cortex excitability in Alzheimer disease: one year follow-up study. Neurosci Lett. 2002;329(3):293–296
   PubMed Web of Science ®Google Scholar
• Pepin JL, Bogacz D, de Pasqua V, et al. Motor cortex inhibition is not impaired in patients with Alzheimer’s disease: evidence from paired transcranial magnetic stimulation. J Neurol Sci. 1999;170(2):119–123.
   PubMed Web of Science ®Google Scholar
• Rossini PM, Rossi S, Babiloni C, et al. Clinical neurophysiology of aging brain: from normal aging to neurodegeneration. Prog Neurobiol. 2007;83(6):375–400.
   PubMed Web of Science ®Google Scholar
• Schirinzi T, Di Lorenzo F, Sancesario GM, et al. Amyloid-mediated cholinergic dysfunction in motor impairment related to Alzheimer’s disease. J Alzheimers dis. 2018;64(2):525–532
   PubMed Web of Science ®Google Scholar
• Trebbastoni A, Gilio F, D’Antonio F, et al. Chronic treatment with rivastigmine in patients with Alzheimer’s disease: a study on primary motor cortex excitability tested by 5 Hz-repetitive transcranial magnetic stimulation. Clin Neurophysiol. 2012;123(5):902–909
   PubMed Web of Science ®Google Scholar
• Wang P, Zhang H, Han L, et al. Cortical function in Alzheimer’s disease and frontotemporal dementia. Transl Neurosci. 2016;7(1):116–125.
   PubMed Web of Science ®Google Scholar
• Wegrzyn M, Teipel SJ, Oltmann I, et al. Structural and functional cortical disconnection in Alzheimer’s disease: a combined study using diffusion tensor imaging and transcranial magnetic stimulation. Psychiatry Res. 2013;212(3):192–200
   PubMed Web of Science ®Google Scholar
• Di Lazzaro V, Oliviero A, Pilato F, et al. Motor cortex hyperexcitability to transcranial magnetic stimulation in Alzheimer’s disease: evidence of impaired glutamatergic neurotransmission?[comment]. Ann Neurol. 2003;53(6):824–825.
   PubMed Web of Science ®Google Scholar
• Zadey S, Buss SS, McDonald K, et al. Higher motor cortical excitability linked to greater cognitive dysfunction in Alzheimer’s disease: results from two independent cohorts. Neurobiol Aging. 2021;108(24–33).
   PubMedGoogle Scholar
• Perretti A, Grossi D, Fragassi N, et al. Evaluation of the motor cortex by magnetic stimulation in patients with Alzheimer disease. J Neurol Sci. 1996;135(1):31–37
   PubMed Web of Science ®Google Scholar
• Sakuma K, Murakami T, Nakashima K. Short latency afferent inhibition is not impaired in mild cognitive impairment. Clin Neurophysiol. 2007;118(7):1460–1463.
   PubMed Web of Science ®Google Scholar
• Nardone R, Bergmann J, Christova M, et al. Short latency afferent inhibition differs among the subtypes of mild cognitive impairment. J neural transm. 2012;119(4):463–471
   PubMed Web of Science ®Google Scholar
• Padovani A, Benussi A, Cantoni V, et al. Diagnosis of mild cognitive impairment due to Alzheimer’s disease with transcranial magnetic stimulation. J Alzheimers dis. 2018;65(1):221–230
   PubMed Web of Science ®Google Scholar
• Tsutsumi R, Hanajima R, Hamada M, et al. Reduced interhemispheric inhibition in mild cognitive impairment. Exp Brain Res. 2012;218(1):21–26
   PubMed Web of Science ®Google Scholar
• Alberici A, Bonato C, Calabria M, et al. The contribution of TMS to frontotemporal dementia variants. Acta Neurol Scand. 2008;118(4):275–280
   PubMed Web of Science ®Google Scholar
• Martorana A, Di Lorenzo F, Esposito Z, et al. Dopamine D₂-agonist rotigotine effects on cortical excitability and central cholinergic transmission in Alzheimer’s disease patients. Neuropharmacology. 2013;64(108–113):108–113
   PubMedGoogle Scholar
• Benussi A, Dell’Era V, Cantoni V, et al. Discrimination of atypical parkinsonisms with transcranial magnetic stimulation. Brain Stimul. 2018;11(2):366–373
   PubMed Web of Science ®Google Scholar
• Nardone R, Bergmann J, Kronbichler M, et al. Abnormal short latency afferent inhibition in early Alzheimer’s disease: a transcranial magnetic demonstration. J Neural Transm (Vienna). 2008;115(11):1557–1562
   PubMed Web of Science ®Google Scholar
• Olazarán J, Hernández-Tamames JA, Molina E, et al. Clinical and anatomical correlates of gait dysfunction in Alzheimer’s disease. J Alzheimers dis. 2013;33(2):495–505
   PubMed Web of Science ®Google Scholar
• Liepert J, Bar KJ, Meske U, et al. Motor cortex disinhibition in Alzheimer’s disease. Clin Neurophysiol. 2001;112(8):1436–1441.
   PubMed Web of Science ®Google Scholar
• Nardone R, Bratti A, Tezzon F. Motor cortex inhibitory circuits in dementia with Lewy bodies and in Alzheimer’s disease. J Neural Transm (Vienna). 2006;113(11):1679–1684.
   PubMed Web of Science ®Google Scholar
• Pierantozzi M, Panella M, Palmieri MG, et al. Different TMS patterns of intracortical inhibition in early onset Alzheimer dementia and frontotemporal dementia. Clin Neurophysiol. 2004;115(10):2410–2418
   PubMed Web of Science ®Google Scholar
• Olazarán J, Prieto J, Cruz I, et al. Cortical excitability in very mild Alzheimer’s disease: a long-term follow-up study. J Neurol. 2010;257(12):2078–2085.
   PubMed Web of Science ®Google Scholar
• Mimura Y, Nishida H, Nakajima S, et al. Neurophysiological biomarkers using transcranial magnetic stimulation in Alzheimer’s disease and mild cognitive impairment: a systematic review and meta-analysis. Neurosci Biobehav Rev. 2021;121(47–59):47–59
   PubMedGoogle Scholar
• Martorana A, Di Lorenzo F, Esposito Z, et al. Dopamine D(2)-agonist rotigotine effects on cortical excitability and central cholinergic transmission in Alzheimer’s disease patients. Neuropharmacology. 2013;64(108–113):108–113.
   PubMedGoogle Scholar
• Koch G, Martorana A, Caltagirone C. Transcranial magnetic stimulation: emerging biomarkers and novel therapeutics in Alzheimer’s disease. Neurosci Lett. 2020;719(134355):134355.
   PubMedGoogle Scholar
• Di Lorenzo F, Ponzo V, Bonnì S, et al. Long-term potentiation-like cortical plasticity is disrupted in Alzheimer’s disease patients independently from age of onset. Ann Neurol. 2016;80(2):202–210
   PubMed Web of Science ®Google Scholar
• Nardone R, Höller Y, Thomschewski A, et al. Dopamine differently modulates central cholinergic circuits in patients with Alzheimer disease and CADASIL. J neural transm. 2014;121(10):1313–1320
   PubMed Web of Science ®Google Scholar
• Martorana A, Esposito Z, Di Lorenzo F, et al. Cerebrospinal fluid levels of Aβ42 relationship with cholinergic cortical activity in Alzheimer’s disease patients. J neural transm. 2012;119(7):771–778
   PubMed Web of Science ®Google Scholar
• Benussi A, Cantoni V, Grassi M, et al. Increasing brain gamma activity improves episodic memory and restores cholinergic dysfunction in Alzheimer’s disease. Ann Neurol. 2022;92(2):322–334
   PubMed Web of Science ®Google Scholar
• Benussi A, Cantoni V, Cotelli MS, et al. Exposure to gamma tACS in Alzheimer’s disease: a randomized, double-blind, sham-controlled, crossover, pilot study. Brain Stimul. 2021;14(3):531–540
   PubMed Web of Science ®Google Scholar
• Bella R, Cantone M, Lanza G, et al. Cholinergic circuitry functioning in patients with vascular cognitive impairment–no dementia. Brain Stimul. 2016;9(2):225–233
   PubMed Web of Science ®Google Scholar
• Hwang YT, Rocchi L, Hammond P, et al. Effect of donepezil on transcranial magnetic stimulation parameters in Alzheimer’s disease. Alzheimer’s Dementia. 2018;4:103–107.
   Google Scholar
• Koch G, Di Lorenzo F, Del Olmo MF, et al. Reversal of LTP-like cortical plasticity in alzheimer’s disease patients with tau-related faster clinical progression. J Alzheimers dis. 2016;50(2):605–616
   PubMed Web of Science ®Google Scholar
• Yildiz FG, Saka E, Elibol B, et al. Modulation of cerebellar-cortical connections in multiple system atrophy type c by cerebellar repetitive transcranial magnetic stimulation. Neuromodulation. 2018;21(4):402–408.
   PubMed Web of Science ®Google Scholar
• Peter J, Lahr J, Minkova L, et al. Contribution of the cholinergic system to verbal memory performance in mild cognitive impairment. J Alzheimers dis. 2016;53(3):991–1001
   PubMed Web of Science ®Google Scholar
• Celebi O, Temucin CM, Elibol B, et al. Short latency afferent inhibition in Parkinson’s disease patients with dementia. Mov Disord. 2012;27(8):1052–1055.
   PubMed Web of Science ®Google Scholar
• Bologna M, Guerra A, Colella D, et al. Bradykinesia in Alzheimer’s disease and its neurophysiological substrates. Clin Neurophysiol. 2020;131(4):850–858
   PubMed Web of Science ®Google Scholar
• Balla C, Maertens de Noordhout A, Pepin JL. Motor cortex excitability changes in mild Alzheimer’s disease are reversed by donepezil. Dement Geriatr Cogn Disord. 2014;38(3–4):264–270.
   PubMed Web of Science ®Google Scholar
• Khedr EM, Ahmed OG, Sayed HM, et al. Electrophysiological differences in cortical excitability in different forms of dementia: a transcranial magnetic stimulation and laboratory biomarkers study. Neurophysiol Clin. 2020;50(3):185–193.
   PubMed Web of Science ®Google Scholar
• Vucic S, Ziemann U, Eisen A, et al. Transcranial magnetic stimulation and amyotrophic lateral sclerosis: pathophysiological insights. J Neurol Neurosurg Psychiatry. 2013;84(84):1161–1170.
   PubMedGoogle Scholar
• Padovani A, Benussi A, Cotelli MS, et al. Transcranial magnetic stimulation and amyloid markers in mild cognitive impairment: impact on diagnostic confidence and diagnostic accuracy. Alzheimer’s Res Ther. 2019;11(1):95
   PubMed Web of Science ®Google Scholar
• Bonnì S, Lupo F, Lo Gerfo E, et al. Altered parietal-motor connections in Alzheimer’s disease patients. J Alzheimers dis. 2013;33(2):525–533
   PubMed Web of Science ®Google Scholar
• Bagattini C, Mutanen TP, Fracassi C, et al. Predicting Alzheimer’s disease severity by means of TMS-EEG coregistration. Neurobiol Aging. 2019;80(38–45):38–45
   PubMedGoogle Scholar
• Di Lazzaro V, Oliviero A, Pilato F, et al. Neurophysiological predictors of long term response to AChE inhibitors in AD patients. J Neurol Neurosurg. 2005;76(8):1064–1069
   Web of Science ®Google Scholar
• Badawy RA, Curatolo JM, Newton M, et al. Changes in cortical excitability differentiate generalized and focal epilepsy. Ann Neurol. 2007;61(4):324–331.
   PubMed Web of Science ®Google Scholar
• Targa Dias Anastacio H, Matosin N, Ooi L. Neuronal hyperexcitability in Alzheimer’s disease: what are the drivers behind this aberrant phenotype? Transl Psychiatry. 2022;12(1):257.
   PubMed Web of Science ®Google Scholar
• Vossel KA, Tartaglia MC, Nygaard HB, et al. Epileptic activity in Alzheimer’s disease: causes and clinical relevance. Lancet Neurol. 2017;16(4):311–322.
   PubMed Web of Science ®Google Scholar
• Csernus EA, Werber T, Kamondi A, et al. The significance of subclinical epileptiform activity in alzheimer’s disease: a review. Front Neurol. 2022;13(856500).
   PubMedGoogle Scholar
• Vossel K, Ranasinghe KG, Beagle AJ, et al. Effect of levetiracetam on cognition in patients with alzheimer disease with and without epileptiform activity: a randomized clinical trial. JAMA Neurol. 2021;78(11):1345–1354
   PubMed Web of Science ®Google Scholar
• Badawy RA, Macdonell RA, Berkovic SF, et al. Predicting seizure control: cortical excitability and antiepileptic medication. Ann Neurol. 2010;67(1):64–73.
   PubMed Web of Science ®Google Scholar
• Koch G, Di Lorenzo F, Bonnì S, et al. Impaired LTP- but not LTD-like cortical plasticity in Alzheimer’s disease patients. J Alzheimers Dis. 2012;31(3):593–599.
   PubMed Web of Science ®Google Scholar
• Cantone M, Lanza G, Ranieri F, et al. Editorial: non-invasive brain stimulation in the study and modulation of metaplasticity in neurological disorders. Front Neurol. 2021;12(721906).
   Google Scholar
• Sundman MH, Lim K, Ton That V, et al. Transcranial magnetic stimulation reveals diminished homoeostatic metaplasticity in cognitively impaired adults. Brain Commun. 2020;2(2):fcaa203
   PubMedGoogle Scholar
• Kumar S, Zomorrodi R, Ghazala Z, et al. Extent of dorsolateral prefrontal cortex plasticity and its association with working memory in patients with alzheimer disease. JAMA Psychiatry. 2017;74(12):1266–1274
   PubMed Web of Science ®Google Scholar
• Cotelli M, Calabria M, Manenti R, et al. Improved language performance in Alzheimer disease following brain stimulation. J Neurol Neurosurg Psychiatry. 2011;82(7):794–797
   PubMed Web of Science ®Google Scholar
• Zhang F, Qin Y, Xie L, et al. High-frequency repetitive transcranial magnetic stimulation combined with cognitive training improves cognitive function and cortical metabolic ratios in Alzheimer’s disease. J neural transm. 2019;126(8):1081–1094.
   PubMed Web of Science ®Google Scholar
• Wu Y, Xu W, Liu X, et al. Adjunctive treatment with high frequency repetitive transcranial magnetic stimulation for the behavioral and psychological symptoms of patients with Alzheimer’s disease: a randomized, double-blind, sham-controlled study. Shanghai Arch Psychiatry. 2015;27(5):280–288.
   PubMedGoogle Scholar
• Rutherford G, Lithgow B, Moussavi Z. Short and long-term effects of rTMS treatment on alzheimer’s disease at different stages: a pilot study. J Exp Neurosci. 2015;9(43–51):JEN.S24004.
   PubMedGoogle Scholar
• Koch G, Di Lorenzo F, Bonnì S, et al. Dopaminergic modulation of cortical plasticity in Alzheimer’s disease patients. Neuropsychopharmacology. 2014;39(11):2654–2661
   PubMed Web of Science ®Google Scholar
• Ahmed MA, Darwish ES, Khedr EM, et al. Effects of low versus high frequencies of repetitive transcranial magnetic stimulation on cognitive function and cortical excitability in Alzheimer’s dementia. J Neurol. 2012;259(1):83–92.
   PubMed Web of Science ®Google Scholar
• Turriziani P, Smirni D, Mangano GR, et al. Low-frequency repetitive transcranial magnetic stimulation of the right dorsolateral prefrontal cortex enhances recognition memory in alzheimer’s disease. J Alzheimers dis. 2019;72(2):613–622
   PubMed Web of Science ®Google Scholar
• Klaassens BL, van Gerven JMA, van der Grond J, et al. Diminished posterior precuneus connectivity with the default mode network differentiates normal aging from alzheimer’s disease. Front Aging Neurosci. 2017;9(97).
   PubMedGoogle Scholar
• Koch G, Bonnì S, Pellicciari MC, et al. Transcranial magnetic stimulation of the precuneus enhances memory and neural activity in prodromal Alzheimer’s disease. Neuroimage. 2018;169:302–311.
   PubMed Web of Science ®Google Scholar
• Brier MR, Thomas JB, Ances BM. Network dysfunction in Alzheimer’s disease: refining the disconnection hypothesis. Brain Connect. 2014;4(5):299–311.
   PubMedGoogle Scholar
• Rabey JM, Dobronevsky E, Aichenbaum S, et al. Repetitive transcranial magnetic stimulation combined with cognitive training is a safe and effective modality for the treatment of Alzheimer’s disease: a randomized, double-blind study. J neural transm. 2013;120(5):813–819.
   PubMed Web of Science ®Google Scholar
• Lee J, Choi BH, Oh E, et al. Treatment of Alzheimer’s disease with repetitive transcranial magnetic stimulation combined with cognitive training: a prospective, randomized, double-blind, placebo-controlled study. J Clin Neurol. 2016;12(1):57–64.
   PubMed Web of Science ®Google Scholar
• Zhao J, Li Z, Cong Y, et al. Repetitive transcranial magnetic stimulation improves cognitive function of Alzheimer’s disease patients. Oncotarget. 2017;8(20):33864–33871
   PubMedGoogle Scholar
• Bentwich J, Dobronevsky E, Aichenbaum S, et al. Beneficial effect of repetitive transcranial magnetic stimulation combined with cognitive training for the treatment of Alzheimer’s disease: a proof of concept study. J Neural Transm (Vienna). 2011;118(3):463–471
   PubMed Web of Science ®Google Scholar
• Sabbagh M, Sadowsky C, Tousi B, et al. Effects of a combined transcranial magnetic stimulation (TMS) and cognitive training intervention in patients with Alzheimer’s disease. Alzheimers Dement. 2020;16(4):641–650
   PubMed Web of Science ®Google Scholar
• Lefaucheur JP, Aleman A, Baeken C, et al. Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS): an update (2014-2018). Clin Neurophysiol. 2020;131(2):474–528.
   PubMed Web of Science ®Google Scholar